RANTES expression in psoriatic skin, and regulation of rantes and IL-8 production in cultured epidermal keratinocytes by active vitamin D3 (tacalcitol)

British Journal of Dermatology

Volumn 138, Issue 1, 1998, Pages 63-70

  Fukuoka, M ^a   Ogino, Y ^a   Sato, H ^a   Ohta, T ^a   Komoriya, K ^a   Nishioka, K ^b   Katayama, I ^b,c  

^a TEIJIN LTD   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 8; RANTES; TACALCITOL;

ARTICLE; DRUG EFFECT; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; PSORIASIS VULGARIS;

CELL CULTURE TECHNIQUES; CYTOKINES; DIHYDROXYCHOLECALCIFEROLS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INTERFERON TYPE II; INTERLEUKIN-8; KERATINOCYTES; PSORIASIS; RANTES; RECOMBINANT PROTEINS; SKIN; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031885312     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1998.02027.x     Document Type: Article

References (37)

1. Lindley IJD, Westeick J, Kunkel SL. Nomenclature announcement - the chemokines. Immunol Today 1993; 14: 24.
2. Baggiolini M, Dewalt B, Moser B. Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv Immunol 1994; 55: 97-179.
3. Kameyoshi Y, Dorschner A, Mallet AI et al. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med 1992; 176: 587-92.
4. Schall TJ, Bacon K, Toy KJ et al. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990; 347: 669-71.
5. Meurer R, Riper GV, Feeney W et al. Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by injection of human RANTES but not human monocyte chemoattractant protein 1, human macrophage inflammatory protein 1α, or human interleukin 8. J Exp Med 1993; 178: 1913-21.
6. Ying S, Barata LT, Meng Q et al. The kinetics of allergen-induced transcription of messenger RNA for monocyte chemotactic protein-3 and RANTES in the skin of human atopic subjects: relationship to eosinophil, T cell, and macrophage recruitment. J Exp Med 1995; 181: 2153-9.
7. Schroder JM, Noso N, Sticherling M et al. Role of eosinophilchemotactic C-C chemokines in cutaneous inflammation. J Leukocyte Biol 1995; 59: 1-5.
8. Sticherling M, Kupper M, Koltrowitz F et al. Detection of the chemokine RANTES in cytokine-stimulated human dermal fibroblasts. J Invest Dermatol 1995; 105: 585-91.
9. Li J, Ireland GW, Farthing PM et al. Epidermal and oral keratinocytes are induced to produce RANTES and IL-8 by cytokine stimulation. J Invest Dermatol 1996; 106: 661-6.
10. Schroder JM, Gregory H, Young J, Christophers E. Neutrophil-activating proteins in psoriasis. J Invest Dermatol 1992; 98: 241-7.
11. Gillitzer R, Berger R, Mielke V et al. Upper keratinocyte of psoriatic skin lesions express high levels of NAP-1/IL-8 mRNA in situ. J Invest Dermatol 1991; 97: 73-9.
12. Anttila HSI, Reitamo S, Erkko P et al. Interleukin-8 immunoreactivity in the skin of healthy subjects and patients with psoriasis. J Invest Dermatol 1992; 98: 96-101.
13. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1 and Th2 and more. Immunol Today 1996; 138: 139-46.
14. Schlaak JF, Buslau M, Jochum W et al. T cells involved in psoriasis vulgaris belong to the Th1 subset. J Invest Dermatol 1994; 102: 145-9.
15. Nickoloff BJ, Karabin GD, Barker JNWN et al. Cellular localization of interleukin-8 and its inducer tumor necrosis factor-alfa in psoriasis. Am J Pathol 1991; 138: 129-40.
16. Ohta Y, Katayama I, Funato T et al. In situ expression of messenger RNA of interleukin-1 and interleukin-6 in psoriasis: interleukin-6 involved in formation of psoriatic lesions. Arch Dermatol Res 1991; 283: 351-6.
17. Rathanaswami P, Hachida M, Sadick M et al. Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. J Biol Chem 1993; 268: 5834-9.
18. Koka AM, Devergne O, Gorgone G et al. Regulation of the production of the RANTES chemokine by endothelial cells. J Immunol 1995; 154: 1870-8.
19. 3 on the growth of human keratinocytes. J Dermatol 1990; 17: 97-103.
20. 3 to induce keratinocyte differentiation. J Dermatol 1990; 17: 707-9.
21. 3 receptor in human leukocytes. Science 1983; 221: 1181-3.
22. Hettmannsperger U, Detmar M, Owsianowski M et al. Cytokine-stimulated human dermal microvascular endothelial cells produce interleukin 6 - inhibition by hydrocortisone, dexamethasone, and calcitriol. J Invest Dermatol 1992; 99: 531-6.
23. 3 is a potent regulator of interleukin-1 induced interleukin-8 expression and production. Biochem Biophys Res Commun 1991; 176: 1020-6.
24. 3 and the immune system. Mol Cell Endocrinol 1985; 43: 113-22.
25. Lundin A, Fredens K, Michaelsson G et al. The eosinophil granulocyte in psoriasis. Br J Dermatol 1990; 122: 181-93.
26. Ueyama K, Yamamura M, Fivenson DF et al. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T helper type I cell mediated response. J Invest Dermatol 1993; 101: 701-5.
27. Tujimoto M, Yip YK, Vilcek J. Interferon-gamma enhances expression of cellular receptors for tumor necrosis factor. J Immunol 1986; 136: 2441-4.
28. Ruggiero V, Tavenier J, Fiers W, Baglioni C. Induction of the synthesis of tumor necrosis factor receptors by interferon-gamma. J Immunol 1986; 136: 2445-50.
29. Yasumoto K, Okamoto S, Mukaida N et al. Tumor necrosis factor α and interferon γ synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-κB-like binding sites of the interleukin 8 gene. J Biol Chem 1992; 267: 22506-11.
30. Nelson PJ, Kim HT, Manning WC et al. Genomic organization and transcriptional regulation of RANTES chemokine gene. J Immunol 1993; 151: 2601-12.
31. Becker S, Daniel EG. Antagonistic and additive effects of IL-4 and interferon-gamma on human monocytes and macrophages: effects on Fc receptors, HLA-D antigens, and superoxide production. Cell Immunol 1990; 129: 351-62.
32. 2. Proc Natl Acad Sci USA 1989; 86: 3803-7.
33. Powrie F, Menon S, Coffman RL. Interleukin-4 and interleukin-10 synergize to inhibit cell mediated immunity in vivo. Eur J Immunol 1993; 23: 3043-8.
34. 3 for psoriasis: report of live cases. Calcif Tissue Int 1986; 38: 119-22.
35. 3 analogue. 1α,24-dihydroxycholecalciferol. Br J Dermatol 1986; 115: 431-3.
36. 3) on cutaneous inflammation, epidermal proliferation and keratinization in psoriasis: a placebo-controlled, double-blind study. Br J Dermatol 1994; 131: 57-63.
37. 3. TV-02) inhibits phorbol ester-induced epidermal proliferation and cutaneous inflammation, and induces epidermal differentiation in mice. Arch Dermatol Res 1996; 288: 656-63.